ClinicalTrials.Veeva

Menu

Advantages of Autologous Platelet-Rich Fibrin Membrane on Growth Factor Levels and Periodontal Healing

A

Ataturk University

Status

Completed

Conditions

Chronic Periodontitis

Treatments

Device: Platelet rich fibrine
Device: Open Flap Debridement

Study type

Interventional

Funder types

Other

Identifiers

NCT02898675
BAP-2011300

Details and patient eligibility

About

Platelet rich fibrin is a second generation platelet concentration which contains various growth factors. The aim of this study is to evaluate the clinical and biochemical efficacy of PRF in subjects of chronic periodontitis in the operation of conventional periodontal flap.

Full description

PRF was developed in 2001 by Choukroun in France, it was the second generation fibrin adhesive, and was used to accelerate the soft and hard tissue healing. Many studies have shown beneficial effects of PRF on osteoconductive filler material in sinus lift operations, treatment of periodontal sulcus defect and treatment of furcation defects. Also PRF contains many growth factors. PRF accelerates periodontal regeneration through the gradually excreted growth factors and contributes to the bone regeneration. In this study, the investigators evaluated the effect of PRF on growth factors and its contribution to periodontal regeneration in subjects with chronic periodontitis.

Enrollment

26 patients

Sex

All

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Patients with CP who had pocket depth ≤ 5 mm and at least two area (grouped as Control and PRF) with horizontal bone loss after initial treatment

Exclusion criteria

  • The subjects excluded in the study had history of systemic disease, were smokers, had allergy to any drug, had need for prophylaxis of antibiotic and had taken antibiotics at least 6 months

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

26 participants in 2 patient groups

Platelet Rich Fibrine
Experimental group
Description:
Platelet Rich Fibrine was applied with open flap debridement in test group.
Treatment:
Device: Platelet rich fibrine
Open Flap Debridement
Active Comparator group
Description:
Platelet Rich Fibrin was not applied to control groups. Only open flap debridement was applied to control groups.
Treatment:
Device: Open Flap Debridement

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems